1. Patient characteristics in the entire study group
Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42

2. Patient characteristics in the 3 subgroups of aortic valve disease severity
Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42

3. Rate of disease progression, expressed as the rate of annual increase in Vmax (m/s/year) in the statin and nonstatin groups
Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42

4. The change in aortic valve disease severity (at least 1 degree) during follow-up in the 3 subgroups
Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42

5. Stepwise multiple linear regression analysis for the independent significant predictors of aortic valve disease progression
Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42

6. Studies assessing the effects of statin therapy on the progression of AS
Antonini-Canterin F, et al. Am J Cardiol 2008;102:738-42